Overwijk WW - Search Results

1

Immunosuppression in melanoma immunotherapy: potential opportunities for intervention.

Lizée G, Radvanyi LG, Overwijk WW, Hwu P. Lizée G, et al. Among authors: overwijk ww. Clin Cancer Res. 2006 Apr 1;12(7 Pt 2):2359s-2365s. doi: 10.1158/1078-0432.CCR-05-2537. Clin Cancer Res. 2006. PMID: 16609059 Review.

2

Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".

Overwijk WW, Restifo NP. Overwijk WW, et al. Crit Rev Immunol. 2000;20(6):433-50. Crit Rev Immunol. 2000. PMID: 11396680 Free PMC article. Review.

3

Immunization against endogenous retroviral tumor-associated antigens.

Kershaw MH, Hsu C, Mondesire W, Parker LL, Wang G, Overwijk WW, Lapointe R, Yang JC, Wang RF, Restifo NP, Hwu P. Kershaw MH, et al. Among authors: overwijk ww. Cancer Res. 2001 Nov 1;61(21):7920-4. Cancer Res. 2001. PMID: 11691813 Free PMC article.

4

Breaking tolerance in cancer immunotherapy: time to ACT.

Overwijk WW. Overwijk WW. Curr Opin Immunol. 2005 Apr;17(2):187-94. doi: 10.1016/j.coi.2005.01.011. Curr Opin Immunol. 2005. PMID: 15766680 Review.

5

Improving antitumor immune responses by circumventing immunoregulatory cells and mechanisms.

Lizée G, Radvanyi LG, Overwijk WW, Hwu P. Lizée G, et al. Among authors: overwijk ww. Clin Cancer Res. 2006 Aug 15;12(16):4794-803. doi: 10.1158/1078-0432.CCR-06-0944. Clin Cancer Res. 2006. PMID: 16914564 Review.

6

IL-21 synergizes with IL-7 to augment expansion and anti-tumor function of cytotoxic T cells.

Liu S, Lizée G, Lou Y, Liu C, Overwijk WW, Wang G, Hwu P. Liu S, et al. Among authors: overwijk ww. Int Immunol. 2007 Oct;19(10):1213-21. doi: 10.1093/intimm/dxm093. Int Immunol. 2007. PMID: 17898044

7

Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models.

Zhu K, Qin H, Cha SC, Neelapu SS, Overwijk W, Lizee GA, Abbruzzese JL, Hwu P, Radvanyi L, Kwak LW, Chang DZ. Zhu K, et al. Vaccine. 2007 Nov 14;25(46):7955-61. doi: 10.1016/j.vaccine.2007.08.050. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17933439

8

Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.

Liu C, Lou Y, Lizée G, Qin H, Liu S, Rabinovich B, Kim GJ, Wang YH, Ye Y, Sikora AG, Overwijk WW, Liu YJ, Wang G, Hwu P. Liu C, et al. Among authors: overwijk ww. J Clin Invest. 2008 Mar;118(3):1165-75. doi: 10.1172/JCI33583. J Clin Invest. 2008. PMID: 18259609 Free PMC article.

9

Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer.

Rabinovich BA, Ye Y, Etto T, Chen JQ, Levitsky HI, Overwijk WW, Cooper LJ, Gelovani J, Hwu P. Rabinovich BA, et al. Among authors: overwijk ww. Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14342-6. doi: 10.1073/pnas.0804105105. Epub 2008 Sep 15. Proc Natl Acad Sci U S A. 2008. PMID: 18794521 Free PMC article.

10

Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy.

Thapa P, Zhang G, Xia C, Gelbard A, Overwijk WW, Liu C, Hwu P, Chang DZ, Courtney A, Sastry JK, Wang PG, Li C, Zhou D. Thapa P, et al. Among authors: overwijk ww. Vaccine. 2009 May 26;27(25-26):3484-8. doi: 10.1016/j.vaccine.2009.01.047. Epub 2009 Feb 5. Vaccine. 2009. PMID: 19200815 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters